<DOC>
	<DOC>NCT02618967</DOC>
	<brief_summary>The purpose of this study is to obtain initial information on the safety and tolerability (effects good or bad), pharmacokinetics (what the body does to the drug), and pharmacodynamics (what the drug does to the body) of a single dose of AMG 570.</brief_summary>
	<brief_title>Single Ascending Dose Study of AMG 570 in Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Lupus Erythematosus, Systemic</mesh_term>
	<criteria>Healthy as determined by the investigator Normal or clinically acceptable ECG Female subjects must be of documented nonreproductive potential Subjects must be current for all vaccinations Other inclusion criteria may apply Current or chronic history of liver disease History of active infections History of significant respiratory disorder Evidence of renal disease Other exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Lupus</keyword>
	<keyword>Healthy Volunteer</keyword>
	<keyword>Safety Study</keyword>
	<keyword>Placebo Control</keyword>
	<keyword>Phase 1</keyword>
</DOC>